Incorporation of fluorescein conjugated function-spacer-lipid constructs into the red blood cell membrane facilitates detection of labeled cells for the duration of ex-vivo storage

详细信息    查看全文

• 作者：Katrina K. Ki^a ; ^b ; ^{kki@redcrossblood.org.au" class="auth_mail" title="E-mail the corresponding author} ; Robert L. Flower^a ; Helen M. Faddy^a ; ^b ; Melinda M. Dean^a
• 关键词：2 ; 3 DPG ; 2 ; 3 diphosphoglycrate ; ATP ; Adenosine triphosphate ; Cr51 ; Chromium-51 ; D ; Day ; FLRO4 ; Fluorescein ; FSL ; Function-spacer-lipid ; FSL-FLRO4 ; Fluorescein conjugated function-spacer-lipid construct ; MFI ; Median fluorescent intensity ; NO ; Nitric oxide ; PRBC ; Packed red blood cells ; RBC ; Red blood cells ; TRIM ; Transfusion-related immunomodulation
• 刊名：Journal of Immunological Methods
• 出版年：2016
• 出版时间：February 2016
• 年：2016
• 卷：429
• 期：Complete
• 页码：66-70
• 全文大小：428 K

文摘

The contribution of ex-vivo storage duration of packed red blood cells (PRBC) to patient outcomes and transfusion-related immunomodulation (TRIM) remains a broadly debated area in transfusion medicine. Kode™ Technology with fluorescein conjugated function-spacer-lipid (FSL-FLRO4) constructs is a tool that can aid in-vitro visualization and tracking of red blood cells (RBC) during routine storage. FSL-FLRO4 is incorporated into the RBC membrane without altering cell function. In this study, we explore the suitability of this technology to label clinical grade PRBC and to determine if the label would be retained during ex-vivo storage. Firstly, to confirm feasibility and assess the limit of detection of FSL-FLRO4 on PRBC at date of expiry (42 days post-collection), we tracked the binding of FSL-FLRO4 on PRBC at weekly intervals during routine storage. Over the time course, all cells remained labelled with FSL-FLRO4, although a decrease in the intensity of labelling was observed (P < 0.0001). We then further investigated differences in FSL-FLRO4 labelling during RBC storage by labelling separated light-young and dense-old RBC from the same PRBC unit. There were no differences in the capacity of FSL-FLRO4 to label these different RBC subsets. Together, these data demonstrate that FSL-FLRO4 is a suitable reagent for labelling PRBC at any point during routine storage. This technology will facilitate the development of immunoassays and transfusion models focused on addressing the mechanisms involved in TRIM.